Back to 
Envestnet Asset Management Inc.
Envestnet Asset Management Inc.
CYTK
Showing 8 of 26 quarters
Position history for Envestnet Asset Management Inc.'s holdings in Cytokinetics, Incorporated
Yes. Envestnet holds 88,521 shares of CYTK (Cytokinetics), worth $7.5M, as of its Q2 2026 13F filing. It increased the position by 53,984 shares (+156.3%) from Q1 2026. Envestnet has held CYTK since Q1 2020, across 26 quarterly 13F filings.
Current Value
$7.5M
Current Shares
88,521
Total Value Change
+$5.8M
Total Shares Change
+55,454
Quarter-by-Quarter History
Other major holders of CYTK: BlackRock, Inc., BlackRock Finance, Inc., FMR LLC